UK and Nigeria launch £10m partnership to tackle growing threat of drug resistance

  15 February 2020

Representatives from Nigeria’s Ministries of Health, Agriculture and Environment celebrated this new collaboration at a reception hosted by the UK’s High Commissioner.

The partnership is part of The Fleming Fund, a £265 million programme by UK Aid to tackle the growing threat of drug resistance – referred to as antimicrobial resistance (AMR) – in low and middle-income countries around the world.

AMR occurs when bacteria survive exposure to antibiotics that would normally kill them. Researchers estimate some 700,000 people die each year from these drug resistant infections. It is believed that if the current trends continue, drug resistance could claim up to 10 million lives a year and cost £85 trillion by 2050.

Further reading: The Fleming Fund
Author(s): The Fleming Fund
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!